{"database": "lobbying", "table": "lobbying_activities", "rows": [[2633530, "133c50d0-c7ed-49f0-85c6-cae2daefb2da", "Q2", "IOWA HOSPITAL ASSOCIATION", 400484391, "IOWA HOSPITAL ASSOCIATION", 2021, "second_quarter", "MMM", "Scheduled and held regular conference calls (approximately monthly) with Iowa's Congressional Delegation staff (House and Senate) to discuss issues related to the COVID-19 pandemic, rural hospital payment reform and other general topics that include the 340B Drug Pricing Program and Provider Relief Funds. \n\nFinally, IHA also stayed in contact with the Centers for Medicare & Medicaid Services on hospital issues related to the COVID-19 pandemic as well as submitted written comment to CMS's FY2022 Inpatient Prospective Payment System proposed rule.", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", null, 26279, 0, 0, "2021-07-07T09:25:26.230000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2633530"], "units": {}, "query_ms": 0.3215551842004061, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}